UBS’s Celanese CE Stock Holding History

UBS’s Portfolio CE Stock Details CE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$211K	Buy	3,600 +2,600	+260%	+$160K	﹤0.01%	5133
2014 Q2	$64K	Sell	1,000 -300	-23%	-$18.2K	﹤0.01%	6520
2014 Q1	$72K	Buy	1,300 +100	+8%	+$5.33K	﹤0.01%	6379
2013 Q4	$66K	Buy	1,200 +500	+71%	+$27.7K	﹤0.01%	6594
2013 Q3	$37K	Buy	700 +200	+40%	+$9.8K	﹤0.01%	7243
2013 Q2	$22K	Buy	+500	New	+$23.5K	﹤0.01%	7760

Other funds holding CE

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS's CE Position: Q3 2014 in Review

UBS increased its Celanese (CE) stake by 31% in Q3 2014, buying an estimated $10.4M and bringing the position to 716,658 shares worth $41.9M. The position accounts for 0.03% of the portfolio, ranked #581.

UBS first reported a position in CE in Q2 2013 and has held it in 6 quarters since. 362 funds tracked by Wall St. Rank hold CE as of Q3 2014.

UBS held 716,658 shares of Celanese worth $41.9M as of Q3 2014.
UBS bought 169,314 Celanese shares in Q3 2014, an estimated $10.4M.
Celanese made up 0.03% of UBS's portfolio in Q3 2014, its #581 holding.
UBS first reported a position in Celanese in Q2 2013 and has held it in 6 quarters since.
362 funds tracked by Wall St. Rank held Celanese as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.